Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology.
Secchiari F, Nuñez SY, Sierra JM, Ziblat A, Regge MV, Raffo Iraolagoitia XL, Rovegno A, Ameri C, Secin FP, Richards N, Ríos Pita H, Vitagliano G, Rico L, Mieggi M, Frascheri F, Bonanno N, Blas L, Trotta A, Friedrich AD, Fuertes MB, Domaica CI, Zwirner NW. Secchiari F, et al. Among authors: rovegno a. Oncoimmunology. 2022 Aug 3;11(1):2104991. doi: 10.1080/2162402X.2022.2104991. eCollection 2022. Oncoimmunology. 2022. PMID: 35936986 Free PMC article.
Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly Inhibitory Phenotype Characterized by Overexpression of CD85j, CD45, CD48 and PD-1.
Ziblat A, Iraolagoitia XLR, Nuñez SY, Torres NI, Secchiari F, Sierra JM, Spallanzani RG, Rovegno A, Secin FP, Fuertes MB, Domaica CI, Zwirner NW. Ziblat A, et al. Among authors: rovegno a. Front Immunol. 2021 Jun 4;12:681615. doi: 10.3389/fimmu.2021.681615. eCollection 2021. Front Immunol. 2021. PMID: 34149719 Free PMC article.
Tumor-Experienced Human NK Cells Express High Levels of PD-L1 and Inhibit CD8+ T Cell Proliferation.
Sierra JM, Secchiari F, Nuñez SY, Iraolagoitia XLR, Ziblat A, Friedrich AD, Regge MV, Santilli MC, Torres NI, Gantov M, Trotta A, Ameri C, Vitagliano G, Pita HR, Rico L, Rovegno A, Richards N, Domaica CI, Zwirner NW, Fuertes MB. Sierra JM, et al. Among authors: rovegno a. Front Immunol. 2021 Sep 20;12:745939. doi: 10.3389/fimmu.2021.745939. eCollection 2021. Front Immunol. 2021. PMID: 34616407 Free PMC article.
Prognostic Factors in De Novo Metastatic Renal Cell Carcinoma: A Report From the Latin American Renal Cancer Group.
Abreu D, Carvalhal G, Gueglio G, Tobia I, Garcia P, Zuñiga A, Meza L, Bengió R, Scorticati C, Castillejos R, Rodriguez F, Autran AM, Gonzales C, Gadu J, Nolazco A, Ameri C, Zampolli H, Langenhin R, Muguruza D, Machado MT, Mingote P, Yandian J, Clavijo J, Nogueira L, Clark O, Secin F, Rovegno A, Vilas A, Barrios E, Decia R, Guimarães G, Glina S, Pal SK, Rodriguez O, Palou J, Spiess P, Lara PN Jr, Linehan WM, Pastore AL, Zequi SC. Abreu D, et al. Among authors: rovegno a. JCO Glob Oncol. 2021 May;7:671-685. doi: 10.1200/GO.20.00621. JCO Glob Oncol. 2021. PMID: 33974442 Free PMC article.
[Physiology of erection].
Casabe Adolfo R, Bechara Amado J, Fernández H, Rovegno A. Casabe Adolfo R, et al. Among authors: rovegno a. Arch Esp Urol. 1995 Jun;48(5):516-25. Arch Esp Urol. 1995. PMID: 7639574 Review. Spanish.
[Analysis of the results with Rigiscan in 93 impotent patients].
Bechara AJ, Casabé AR, Wizenberg P, Bantar CE, Rovegno A, D'Osvaldo C, Rey HM, Fernández H, Moccellini Iturralde YJ. Bechara AJ, et al. Among authors: rovegno a. Arch Esp Urol. 1995 Jun;48(5):531-9. Arch Esp Urol. 1995. PMID: 7639575 Clinical Trial. Spanish.
23 results